• Phase 1 clinical trial ongoing
• Phase 3 clinical trial ongoing
- First patient in Oct. 2022
Biological Drug Product, Formulation, mAb Formulation
Secukinumab (Cosentyx®) biosimilar
Related products
-
Biological Drug ProductSemaglutide Injection(Ozempic)
Indications:Glycemic Control
USA, EU, China approval single dose
-
-
Biological Drug ProductAdalimumab (Humira®) biosimilar
-
Formulation
Rocuronium Bromide Injection